Best Major Pharmaceuticals Stocks 2021

Filters
Select UI View

Vs.
Select Industry

Market Cap

$ 0.00 to $ 410.34 B

Stock Prices

$0.09 to $206.92

Returns

-86.29% to 706.12%

Price / Earning Ratio

-59.62 to 548

Johnson & Johnson

JNJ

Symbol
JNJ

Exchange
NEW YORK STOCK EXCHANGE, INC.

Sector
Health Technology

Website
https://www.jnj.com/

Market Cap
$ 410.34 B

P/E Ratio
28.33

YTD Change
-0.15%

52 Week Range
$106.29 - $172.57

Stock Name
Johnson & Johnson

CEO
Alex Gorsky

Employees

Address
New brunswick , New jersey

Johnson & Johnson or JNJ is traded on NEW YORK STOCK EXCHANGE, INC.. The total market value of the company is $ 410.34 B. Alex Gorsky is the CEO of the company. Total employees of Johnson & Johnson are . The P/E Ratio of Johnson & Johnson is 28.33 and year till date stock price change percent is -0.15%.

Lilly(Eli) & Co

LLY

Symbol
LLY

Exchange
NEW YORK STOCK EXCHANGE, INC.

Sector
Health Technology

Website
https://www.lilly.com/

Market Cap
$ 198.32 B

P/E Ratio
30.47

YTD Change
22.45%

52 Week Range
$114.87 - $217.09

Stock Name
Lilly(Eli) & Co

CEO
David Ricks

Employees

Address
Indianapolis , Indiana

Lilly(Eli) & Co or LLY is traded on NEW YORK STOCK EXCHANGE, INC.. The total market value of the company is $ 198.32 B. David Ricks is the CEO of the company. Total employees of Lilly(Eli) & Co are . The P/E Ratio of Lilly(Eli) & Co is 30.47 and year till date stock price change percent is 22.45%.

Pfizer Inc.

PFE

Symbol
PFE

Exchange
NEW YORK STOCK EXCHANGE, INC.

Sector
Health Technology

Website
https://www.pfizer.com/

Market Cap
$ 191.81 B

P/E Ratio
20.11

YTD Change
-5.52%

52 Week Range
$26.77 - $42.62

Stock Name
Pfizer Inc.

CEO
Albert Bourla

Employees

Address
New york , New york

Pfizer Inc. or PFE is traded on NEW YORK STOCK EXCHANGE, INC.. The total market value of the company is $ 191.81 B. Albert Bourla is the CEO of the company. Total employees of Pfizer Inc. are . The P/E Ratio of Pfizer Inc. is 20.11 and year till date stock price change percent is -5.52%.

Abbvie Inc

ABBV

Symbol
ABBV

Exchange
NEW YORK STOCK EXCHANGE, INC.

Sector
Health Technology

Website
https://www.abbvie.com/

Market Cap
$ 188.42 B

P/E Ratio
39.23

YTD Change
0.75%

52 Week Range
$59.38 - $113.10

Stock Name
Abbvie Inc

CEO
Richard Gonzalez

Employees

Address
North chicago , Illinois

Abbvie Inc or ABBV is traded on NEW YORK STOCK EXCHANGE, INC.. The total market value of the company is $ 188.42 B. Richard Gonzalez is the CEO of the company. Total employees of Abbvie Inc are . The P/E Ratio of Abbvie Inc is 39.23 and year till date stock price change percent is 0.75%.

Merck & Co Inc

MRK

Symbol
MRK

Exchange
NEW YORK STOCK EXCHANGE, INC.

Sector
Health Technology

Website
http://www.merck.com/

Market Cap
$ 185.04 B

P/E Ratio
26.31

YTD Change
-10.44%

52 Week Range
$63.76 - $86.48

Stock Name
Merck & Co Inc

CEO
Kenneth Frazier

Employees

Address
Kenilworth , New jersey

Merck & Co Inc or MRK is traded on NEW YORK STOCK EXCHANGE, INC.. The total market value of the company is $ 185.04 B. Kenneth Frazier is the CEO of the company. Total employees of Merck & Co Inc are . The P/E Ratio of Merck & Co Inc is 26.31 and year till date stock price change percent is -10.44%.

Bristol-Myers Squibb Co.

BMY

Symbol
BMY

Exchange
NEW YORK STOCK EXCHANGE, INC.

Sector
Health Technology

Website
https://www.bms.com/

Market Cap
$ 135.39 B

P/E Ratio
-15.15

YTD Change
-2.5%

52 Week Range
$44.35 - $67.16

Stock Name
Bristol-Myers Squibb Co.

CEO
Giovanni Caforio

Employees

Address
New york , New york

Bristol-Myers Squibb Co. or BMY is traded on NEW YORK STOCK EXCHANGE, INC.. The total market value of the company is $ 135.39 B. Giovanni Caforio is the CEO of the company. Total employees of Bristol-Myers Squibb Co. are . The P/E Ratio of Bristol-Myers Squibb Co. is -15.15 and year till date stock price change percent is -2.5%.

Allakos Inc

ALLK

Symbol
ALLK

Exchange
NASDAQ/NGS (GLOBAL SELECT MARKET)

Sector
Health Technology

Website
http://www.allakos.com/

Market Cap
$ 6.57 B

P/E Ratio

YTD Change
-9.83%

52 Week Range
$41.60 - $157.98

Stock Name
Allakos Inc

CEO
Robert Alexander

Employees

Address
Redwood city , California

Allakos Inc or ALLK is traded on NASDAQ/NGS (GLOBAL SELECT MARKET). The total market value of the company is $ 6.57 B. Robert Alexander is the CEO of the company. Total employees of Allakos Inc are . The P/E Ratio of Allakos Inc is and year till date stock price change percent is -9.83%.

Turning Point Therapeutics Inc

TPTX

Symbol
TPTX

Exchange
NASDAQ/NGS (GLOBAL SELECT MARKET)

Sector
Health Technology

Website

Market Cap
$ 5.48 B

P/E Ratio

YTD Change
-6.8%

52 Week Range
$31.30 - $141.30

Stock Name
Turning Point Therapeutics Inc

CEO

Employees

Turning Point Therapeutics Inc or TPTX is traded on NASDAQ/NGS (GLOBAL SELECT MARKET). The total market value of the company is $ 5.48 B. is the CEO of the company. Total employees of Turning Point Therapeutics Inc are . The P/E Ratio of Turning Point Therapeutics Inc is and year till date stock price change percent is -6.8%.

Biohaven Pharmaceutical Holding Company Ltd

BHVN

Symbol
BHVN

Exchange
NEW YORK STOCK EXCHANGE, INC.

Sector
Health Technology

Website
http://biohavenpharma.com/

Market Cap
$ 5.20 B

P/E Ratio

YTD Change
-1.24%

52 Week Range
$26.56 - $100.77

Stock Name
Biohaven Pharmaceutical Holding Company Ltd

CEO
Vlad Coric

Employees

Address
New haven , Connecticut

Biohaven Pharmaceutical Holding Company Ltd or BHVN is traded on NEW YORK STOCK EXCHANGE, INC.. The total market value of the company is $ 5.20 B. Vlad Coric is the CEO of the company. Total employees of Biohaven Pharmaceutical Holding Company Ltd are . The P/E Ratio of Biohaven Pharmaceutical Holding Company Ltd is and year till date stock price change percent is -1.24%.

Forty Seven, Inc.

FTSV

Forty Seven, Inc. develops therapies that target cancer immune evasion pathways. It develops Hu5F9-G4, a monoclonal antibody against human CD47 that potentially has applications spanning multiple tumor types and treatment modalities. The company was founded by Irving L. Weissman, Ravi Majeti, Mark Chao and Jens-Peter Volkmer in 2014 and is headquartered in Menlo Park, CA.

Symbol
FTSV

Exchange
NASDAQ

Sector
Health Technology

Website
http://www.fortyseveninc.com

Market Cap
$ 4.60 B

P/E Ratio
-38.73

YTD Change
0%

52 Week Range
$5.53 - $95.52

Stock Name
Forty Seven Inc

CEO

Employees
68

Address
Menlo Park , CA

Forty Seven, Inc. or FTSV is traded on NASDAQ. The total market value of the company is $ 4.60 B. is the CEO of the company. Total employees of Forty Seven, Inc. are 68. The P/E Ratio of Forty Seven Inc is -38.73 and year till date stock price change percent is 0%.

Reata Pharmaceuticals Inc

RETA

Symbol
RETA

Exchange
NASDAQ/NMS (GLOBAL MARKET)

Sector
Health Technology

Website
https://reatapharma.com/

Market Cap
$ 3.97 B

P/E Ratio
-17.27

YTD Change
2.65%

52 Week Range
$88.17 - $195.09

Stock Name
Reata Pharmaceuticals Inc - Class A

CEO
J. Warren Huff

Employees

Address
Plano , Texas

Reata Pharmaceuticals Inc or RETA is traded on NASDAQ/NMS (GLOBAL MARKET). The total market value of the company is $ 3.97 B. J. Warren Huff is the CEO of the company. Total employees of Reata Pharmaceuticals Inc are . The P/E Ratio of Reata Pharmaceuticals Inc - Class A is -17.27 and year till date stock price change percent is 2.65%.

Apellis Pharmaceuticals Inc

APLS

Symbol
APLS

Exchange
NASDAQ/NGS (GLOBAL SELECT MARKET)

Sector
Health Technology

Website
http://apellis.com/

Market Cap
$ 3.92 B

P/E Ratio

YTD Change
-13.27%

52 Week Range
$16.85 - $58.47

Stock Name
Apellis Pharmaceuticals Inc

CEO
Cedric Francois

Employees

Address
Waltham , Massachusetts

Apellis Pharmaceuticals Inc or APLS is traded on NASDAQ/NGS (GLOBAL SELECT MARKET). The total market value of the company is $ 3.92 B. Cedric Francois is the CEO of the company. Total employees of Apellis Pharmaceuticals Inc are . The P/E Ratio of Apellis Pharmaceuticals Inc is and year till date stock price change percent is -13.27%.

SpringWorks Therapeutics Inc

SWTX

Symbol
SWTX

Exchange
NASDAQ/NGS (GLOBAL SELECT MARKET)

Sector
Health Technology

Website

Market Cap
$ 3.64 B

P/E Ratio

YTD Change
2.92%

52 Week Range
$19.50 - $96.48

Stock Name
SpringWorks Therapeutics Inc

CEO

Employees

SpringWorks Therapeutics Inc or SWTX is traded on NASDAQ/NGS (GLOBAL SELECT MARKET). The total market value of the company is $ 3.64 B. is the CEO of the company. Total employees of SpringWorks Therapeutics Inc are . The P/E Ratio of SpringWorks Therapeutics Inc is and year till date stock price change percent is 2.92%.

Principia Biopharma, Inc.

PRNB

Principia Biopharma, Inc. is a biopharmaceutical company, which engages in designing and developing oral therapies to patients with significant unmet medical needs in immunology and oncology. It operates through Tailored Covalency platform, which enables to develop small molecule inhibitors of enzymes and receptor ligands with potencies and selectivities that rival those of injectable biologics, yet maintain the convenience of a pill. Its product pipeline includes PRN1008, PRN2246, PRN1371, and immunoproteasome inhibitor. The company was founded by Jack Taunton and Richard A. Miller on October 6, 2008 and is headquartered in South San Francisco, CA.

Symbol
PRNB

Exchange
NASDAQ

Sector
Health Technology

Website
http://www.principiabio.com

Market Cap
$ 3.32 B

P/E Ratio
-41.96

YTD Change
0%

52 Week Range
$25.35 - $101.89

Stock Name
Principia Biopharma, Inc.

CEO
Martin Babler

Employees
103

Address
South San Francisco , CA

Principia Biopharma, Inc. or PRNB is traded on NASDAQ. The total market value of the company is $ 3.32 B. Martin Babler is the CEO of the company. Total employees of Principia Biopharma, Inc. are 103. The P/E Ratio of Principia Biopharma, Inc. is -41.96 and year till date stock price change percent is 0%.

Karuna Therapeutics Inc

KRTX

Symbol
KRTX

Exchange
NASDAQ/NMS (GLOBAL MARKET)

Sector
Health Technology

Website

Market Cap
$ 3.26 B

P/E Ratio

YTD Change
18.46%

52 Week Range
$52.62 - $146.97

Stock Name
Karuna Therapeutics Inc

CEO

Employees

Karuna Therapeutics Inc or KRTX is traded on NASDAQ/NMS (GLOBAL MARKET). The total market value of the company is $ 3.26 B. is the CEO of the company. Total employees of Karuna Therapeutics Inc are . The P/E Ratio of Karuna Therapeutics Inc is and year till date stock price change percent is 18.46%.

Quanterix Corp

QTRX

Symbol
QTRX

Exchange
NASDAQ/NMS (GLOBAL MARKET)

Sector
Health Technology

Website

Market Cap
$ 2.42 B

P/E Ratio
-59.62

YTD Change
42.5%

52 Week Range
$10.89 - $92.57

Stock Name
Quanterix Corp

CEO

Employees

Quanterix Corp or QTRX is traded on NASDAQ/NMS (GLOBAL MARKET). The total market value of the company is $ 2.42 B. is the CEO of the company. Total employees of Quanterix Corp are . The P/E Ratio of Quanterix Corp is -59.62 and year till date stock price change percent is 42.5%.

Ra Pharmaceuticals, Inc.

RARX

Ra Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery and development of peptide-based drugs. It uses Extreme Diversity platform that allows to produce synthetic macrocyclic peptides. The company was founded by James W. Broderick and Douglas A. Treco on June 27, 2008 and is headquartered in Cambridge, MA.

Symbol
RARX

Exchange
NASDAQ

Sector
Health Technology

Website
http://www.rapharma.com

Market Cap
$ 2.26 B

P/E Ratio
-20.91

YTD Change
0%

52 Week Range
$19.64 - $48.02

Stock Name
Ra Pharmaceuticals, Inc.

CEO
Douglas A. Treco

Employees
89

Address
Cambridge , MA

Ra Pharmaceuticals, Inc. or RARX is traded on NASDAQ. The total market value of the company is $ 2.26 B. Douglas A. Treco is the CEO of the company. Total employees of Ra Pharmaceuticals, Inc. are 89. The P/E Ratio of Ra Pharmaceuticals, Inc. is -20.91 and year till date stock price change percent is 0%.

IGM Biosciences Inc

IGMS

Symbol
IGMS

Exchange
NASDAQ/NGS (GLOBAL SELECT MARKET)

Sector
Health Technology

Website
http://igmbio.com/

Market Cap
$ 1.90 B

P/E Ratio

YTD Change
-10.63%

52 Week Range
$27.55 - $133.00

Stock Name
IGM Biosciences Inc

CEO

Employees

Address
Mountain view , California

IGM Biosciences Inc or IGMS is traded on NASDAQ/NGS (GLOBAL SELECT MARKET). The total market value of the company is $ 1.90 B. is the CEO of the company. Total employees of IGM Biosciences Inc are . The P/E Ratio of IGM Biosciences Inc is and year till date stock price change percent is -10.63%.

Akcea Therapeutics Inc

AKCA

Symbol
AKCA

Exchange
NASDAQ/NGS (GLOBAL SELECT MARKET)

Sector
Health Technology

Website
http://akceatx.com/

Market Cap
$ 1.85 B

P/E Ratio

YTD Change
0%

52 Week Range
$0.00 - $18.17

Stock Name
Akcea Therapeutics Inc

CEO
Damien McDevitt

Employees

Address
Boston , Massachusetts

Akcea Therapeutics Inc or AKCA is traded on NASDAQ/NGS (GLOBAL SELECT MARKET). The total market value of the company is $ 1.85 B. Damien McDevitt is the CEO of the company. Total employees of Akcea Therapeutics Inc are . The P/E Ratio of Akcea Therapeutics Inc is and year till date stock price change percent is 0%.

Krystal Biotech Inc

KRYS

Symbol
KRYS

Exchange
NASDAQ/NMS (GLOBAL MARKET)

Sector
Health Technology

Website
https://www.krystalbio.com/

Market Cap
$ 1.61 B

P/E Ratio

YTD Change
20.94%

52 Week Range
$33.08 - $87.29

Stock Name
Krystal Biotech Inc

CEO

Employees

Address
Pittsburgh , Pennsylvania

Krystal Biotech Inc or KRYS is traded on NASDAQ/NMS (GLOBAL MARKET). The total market value of the company is $ 1.61 B. is the CEO of the company. Total employees of Krystal Biotech Inc are . The P/E Ratio of Krystal Biotech Inc is and year till date stock price change percent is 20.94%.

Zymeworks Inc

ZYME

Symbol
ZYME

Exchange
NEW YORK STOCK EXCHANGE, INC.

Sector
Health Technology

Website
https://www.zymeworks.com/

Market Cap
$ 1.51 B

P/E Ratio
-9.2

YTD Change
-29.29%

52 Week Range
$20.33 - $59.03

Stock Name
Zymeworks Inc

CEO

Employees

Address
Vancouver , British columbia

Zymeworks Inc or ZYME is traded on NEW YORK STOCK EXCHANGE, INC.. The total market value of the company is $ 1.51 B. is the CEO of the company. Total employees of Zymeworks Inc are . The P/E Ratio of Zymeworks Inc is -9.2 and year till date stock price change percent is -29.29%.

Y-Mabs Therapeutics Inc

YMAB

Symbol
YMAB

Exchange
NASDAQ/NGS (GLOBAL SELECT MARKET)

Sector
Health Technology

Website

Market Cap
$ 1.42 B

P/E Ratio

YTD Change
-34.66%

52 Week Range
$14.16 - $55.22

Stock Name
Y-Mabs Therapeutics Inc

CEO

Employees

Y-Mabs Therapeutics Inc or YMAB is traded on NASDAQ/NGS (GLOBAL SELECT MARKET). The total market value of the company is $ 1.42 B. is the CEO of the company. Total employees of Y-Mabs Therapeutics Inc are . The P/E Ratio of Y-Mabs Therapeutics Inc is and year till date stock price change percent is -34.66%.

Constellation Pharmaceuticals Inc

CNST

Symbol
CNST

Exchange
NASDAQ/NGS (GLOBAL SELECT MARKET)

Sector
Health Technology

Website

Market Cap
$ 1.25 B

P/E Ratio

YTD Change
-8.5%

52 Week Range
$17.00 - $50.90

Stock Name
Constellation Pharmaceuticals Inc

CEO

Employees

Constellation Pharmaceuticals Inc or CNST is traded on NASDAQ/NGS (GLOBAL SELECT MARKET). The total market value of the company is $ 1.25 B. is the CEO of the company. Total employees of Constellation Pharmaceuticals Inc are . The P/E Ratio of Constellation Pharmaceuticals Inc is and year till date stock price change percent is -8.5%.

Arcturus Therapeutics Holdings Inc

ARCT

Symbol
ARCT

Exchange
NASDAQ/NMS (GLOBAL MARKET)

Sector
Health Technology

Website

Market Cap
$ 1.14 B

P/E Ratio

YTD Change
-0.18%

52 Week Range
$8.51 - $129.71

Stock Name
Arcturus Therapeutics Holdings Inc

CEO

Employees

Arcturus Therapeutics Holdings Inc or ARCT is traded on NASDAQ/NMS (GLOBAL MARKET). The total market value of the company is $ 1.14 B. is the CEO of the company. Total employees of Arcturus Therapeutics Holdings Inc are . The P/E Ratio of Arcturus Therapeutics Holdings Inc is and year till date stock price change percent is -0.18%.

Akero Therapeutics Inc

AKRO

Symbol
AKRO

Exchange
NASDAQ/NGS (GLOBAL SELECT MARKET)

Sector
Health Technology

Website
https://www.akerotx.com/

Market Cap
$ 1.06 B

P/E Ratio

YTD Change
18.11%

52 Week Range
$10.78 - $41.16

Stock Name
Akero Therapeutics Inc

CEO

Employees

Address
South san francisco , California

Akero Therapeutics Inc or AKRO is traded on NASDAQ/NGS (GLOBAL SELECT MARKET). The total market value of the company is $ 1.06 B. is the CEO of the company. Total employees of Akero Therapeutics Inc are . The P/E Ratio of Akero Therapeutics Inc is and year till date stock price change percent is 18.11%.

Best Major Pharmaceuticals Stocks List

LogoStockMarket Value
No matching records found

Tags

Best Pharmaceuticals: Major Stocks 2019
Top Pharmaceuticals: Major Stocks
Biggest Pharmaceuticals: Major Stocks
Best Pharmaceuticals: Major Stocks in United States
Pharmaceuticals: Major Stocks to watch on
Best Pharmaceuticals: Major Stocks to Invest in